LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling

Oncogene
Jianming TangHaizhong Feng

Abstract

Recent molecularly targeted approach gains advance in breast cancer treatment. However, the estimated 5-year survival rate has not met the desired expectation for improvement, especially for patients with triple-negative breast cancer (TNBC). Here we report that the lncRNA PVT1 promotes KLF5/beta-catenin signaling to drive TNBC tumorigenesis. PVT1 is upregulated in clinical TNBC tumors. Using genetic approaches targeting PVT1 in TNBC cells, we found that PVT1 depletion inhibited cell proliferation, colony formation, and orthotopic xenograft tumor growth. Mechanistically, PVT1 binds with KLF5 and increases its stability via BAP1, which upregulates beta-catenin signaling, resulting in enhanced TNBC tumorigenesis. PVT1, KLF5, and beta-catenin were also revealed to be co-expressed in clinical TNBC samples. Our findings uncover a new singaling pathway to mediate TNBC, and provide PVT1 as a new target for improving treatment of TNBC.

References

Mar 1, 1989·Molecular and Cellular Biology·E Shtivelman, J M Bishop
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·S Y LinM C Hung
Apr 28, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dan TongRobert Zeillinger
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yinghui GuanJoe W Gray
Jul 3, 2009·Genes & Development·Jeremy E WiluszDavid L Spector
Apr 17, 2010·The American Journal of Pathology·Andrey I KhramtsovKathleen H Goss
Mar 15, 2014·Cancer Research·Takeo NakayaRyozo Nagai
Jul 22, 2014·Nature·Yuen-Yi TsengAnindya Bagchi
Jul 22, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Fang WangShu-Han Sun
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Oct 19, 2016·Nature Reviews. Clinical Oncology·Giampaolo BianchiniLuca Gianni
Aug 30, 2016·The Journal of Clinical Investigation·Robert A JonesEldad Zacksenhaus
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mi-Die XuXiang Du
Aug 15, 2017·The Journal of Clinical Investigation·Wanjin LiYongfeng Shang

❮ Previous
Next ❯

Citations

Apr 16, 2019·Technology in Cancer Research & Treatment·Tianzhu ZhangZhongxin Lu
Jul 13, 2019·Journal of Cellular Physiology·Soudeh Ghafouri-FardMohammad Taheri
Feb 15, 2020·Molecular Oncology·Mieke R Van BockstalCarolien H M van Deurzen
May 15, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A GhadiriP Bagheri
Sep 23, 2020·Journal of Clinical Laboratory Analysis·Chuanhui XunJiangtao Chen
Mar 20, 2020·Molecular Cancer·Francesca CrudeleStefano Volinia
Mar 3, 2020·Frontiers in Oncology·Onayemi Titilayo OnagoruwaOlorunseun O Ogunwobi
Sep 29, 2020·Cancer Management and Research·Hongtao WangYuanrong Yang
Jun 30, 2019·Frontiers in Oncology·Camille DerderianOlorunseun O Ogunwobi
Jan 31, 2020·Frontiers in Oncology·Esraa A SalamaHend M El Tayebi
Dec 26, 2018·Journal of Cellular Biochemistry·Zhihui LiuXiaojie Song
Dec 2, 2020·Biochemical Society Transactions·Taruna RajagopalNageswara Rao Dunna
Dec 15, 2020·Cell Proliferation·Wenwen ZhangJinhai Tang
May 3, 2020·G3 : Genes - Genomes - Genetics·Gargi PalOlorunseun O Ogunwobi
Nov 3, 2020·Frontiers in Oncology·Kaifee Arman, Tarik Möröy
Nov 17, 2020·Frontiers in Oncology·Olorunseun O Ogunwobi, Miguel F Segura
Dec 18, 2020·Frontiers in Genetics·Marina AznaourovaLeon N Schulte
Dec 30, 2020·International Journal of Molecular Sciences·Miguel Ángel Cáceres-DuránAmanda Ferreira Vidal
Mar 7, 2021·Non-coding RNA·Didem Karakas, Bulent Ozpolat
Feb 26, 2021·Pathology, Research and Practice·Soudeh Ghafouri-FardMohammad Taheri
Dec 20, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jianping ZhangXian Wang

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
xenograft
immunoprecipitation
PCR
pull-down
pull down
Assay

Software Mentioned

GraphPad
GraphPad Prism

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.